Obesity Therapeutics: Understanding market dynamics (presentation)DatamonitorApril 13, 2007 21 Pages - SKU: DFMN1480674 |
| Introduction Obesity Therapeutics: Understanding Market Dynamics, a presentation given by Datamonitor at the Obesity Drug Development Summit in July 2006. Scope An overview of the obesity epidemic given by Datamonitor's Healthcare team. Lists of current obesity drugs and those in development. Highlights It is estimated that 44% of US adults and 29% of European adults are currently considered Dieters. Reasons to Purchase Understand the current state and growth rates of obesity. Assess the treatment options for obesity including drug types. Please note, this file is delivered as a PowerPoint Presentation. |
Related Markets
- Diseases & Conditions
- Obesity
- Food
- Diet Food & Weight Loss
- Pharmaceuticals
- Research & Development
- Drug Discovery
Drug Discovery Reports
- Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
- Non-Alcoholic Steatohepatitis Global Clinical Trials Review, H1, 2012
- Tachycardia (Tachyarrhythmias) Global Clinical Trials Review, H1, 2012
- Restless Legs Syndrome Global Clinical Trials Review, H1, 2012
- Lung Injury Global Clinical Trials Review, H1, 2012
